STAAR Surgical Corp (STAA): Utang-utang marang kapitalisasi buku

STAAR Surgical Company (STAA) is the creator of patented Collamer lenses, offering a premium alternative to laser surgeries without corneal damage. The asset value tracked on the chart is currently fixed at 0.10. The company implements EVO ICL biocompatible systems for reversible vision restoration. Meanwhile, the enterprise maintains in-house optics production, outsourcing only packaging to third-party contractors to minimize risks.

This ratio determines the relationship between total liabilities and equity, reflecting the business's reliance on debt financing and its vulnerability to rising interest rates. By analyzing the trajectory of financial leverage, investors assess the margin of safety for STAAR Surgical Company (STAA) against macroeconomic shocks, which is critical for the elective ophthalmology surgery segment that depends on the solvency of private clients.